Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

NCT00916747 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Progeria

Interventions

DRUG: Lonafarnib, Zoledronic Acid, and Pravastatin

Sponsor

Boston Children's Hospital

Collaborators

[object Object]
[object Object]
[object Object]